Drug Discovery Unit
We translate basic science into lead compounds to validate putative drug targets, to use as tools to investigate disease pathways and, when appropriate, advance to pre-clinical drug candidates.
We work to biotech style philosophy and standards incorporating, dynamic, goal driven project management based on target product profiles and compound selection criteria. Our major research themes are:
- neglected tropical diseases
- innovative targets and pathways
The DDU has all of the capabilities required for:
- early phase drug discovery
- assay development
- high throughput screening
- cell biology
- medicinal chemistry
- structural biology
- computational chemistry
- DMPK
All of these capabilities operate under one management structure to ensure an integrated approach and rapid progress.
Currently the team is about 120 people and includes substantial experience from the pharmaceutical/ biotech sector. This website contains details of current programmes and supporting infrastructure.
Head of Unit
person
Executive
person
person
person
person
person
person
person
person
person
Leadership
Name | Role | |
---|---|---|
Dr Laura Cleghorn | TB Portfolio Manager | L.A.T.Cleghorn@dundee.ac.uk |
Dr Vincent Postis | Molecular Interaction Team Leader | vpostis001@dundee.ac.uk |
Dr Gary Tarver | Synthetic Methodologies Team Leader | g.j.tarver@dundee.ac.uk |
Dr Duncan Scott | Team Leader | dscott004@dundee.ac.uk |
Publications
News
News
The University of Dundee's annual Venture competition has once again showcased the innovative prowess of its students, graduates, and staff
News
The Blues and Colours Awards Ceremony celebrates the finest in student sport at the University of Dundee, across the country, and recognises achievements by students for their competitive success or club commitments as a volunteer.
Press release
University of Dundee students have raised more than £11,500 for humanitarian relief in Gaza